UNSPSC 51263171: Penbutolol sulfate

This classification denotes a beta-adrenergic blocking agent and antiarrhythmic agent with the molecular formula 2C18H29NO2.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier US71433228, chemically known as 2-propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (s)-, sulfate (2:1) (salt) but more generally known as penbutolol sulfate, which bears US NIH Compound Identifier 38010.

UNSPSC 51263171 Penbutolol sulfate is a Commodity code for a specific pharmaceutical product, but the recent state and local solicitation activity under this code does not reflect pharmaceutical procurement matching the code's nominal scope. Seminole County, Florida posted an IFB (IFB60459723LAS) in June 2026 for naloxone and drug deactivation systems — a public health supply entirely distinct from penbutolol sulfate, a beta-blocker medication. This mismatch suggests the code may have been misapplied to the county's solicitation, or that the data aggregation has conflated unrelated commodities.

The source contains no evidence of state and local procurement activity for penbutolol sulfate itself. The single recent opportunity documents acquisition of naloxone and safe drug deactivation systems by a county health department through competitive bidding, with quarterly deliveries required to a specific site in Sanford, Florida and a two-year initial term with one-year renewal option. Without supporting opportunities that actually reflect pharmaceutical acquisition under the 51263171 code, no reliable characterization of issuing-body mix, geographic concentration, or market activity for penbutolol sulfate can be made. A business development professional evaluating this code should treat the current signal as a data quality issue rather than a market indicator.